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Abstract
Introduction: Our aim in the present study was to determine whether a disease-specific self-management
program for primary care patients with osteoarthritis (OA) of the knee (the Osteoarthritis of the Knee Self-
Management Program (OAK)) implemented by health care professionals would achieve and maintain clinically
meaningful improvements in health-related outcomes compared with a control group.
Methods: Medical practitioners referred 146 primary care patients with OA of the knee. Volunteers with coexistent
inflammatory joint disease or serious comorbidities were excluded. Randomisation was to either a control group or
the OAK group. The OAK group completed a 6-week self-management program. The control group had a 6-month
waiting period before entering the OAK program. Assessments were taken at baseline, 8 weeks and 6 months. The
primary outcomes were the results measured using the Western Ontario and McMaster Universities Arthritis Index
(WOMAC) Pain and Function subscales on the Short Form 36 version 1 questionnaire (SF-36) Secondary outcomes
were Visual Analogue Scale (VAS) pain, Timed Up & Go Test (TUG), knee range of motion and quadriceps and
hamstring strength-isometric contraction. Responses to treatment (responders) and minimal clinically important
improvements (MCIIs) were determined.
Results: In the OAK group, VAS pain improved from baseline to week 8 from mean (SEM) 5.21 (0.30) to 3.65 (0.29)
(P ≤ 0.001). During this period, improvements in the OAK group compared with the control group and responses
to treatment were demonstrated according to the following outcomes: WOMAC Pain, Physical Function and Total
dimensions, as well as SF-36 Physical Function, Role Physical, Body Pain, Vitality and Social Functioning domains. In
addition, from baseline to week 8, the proportion of MCIIs was greater among the OAK group than the control
group for all outcomes. For the period between baseline and month 6, WOMAC Pain, Physical Function and Total
dimensions significantly improved in the OAK group compared to the control group, as did the SF-36 Physical
Function, Role Physical, Body Pain, Vitality and Social Functioning domains, as well as hamstring strength in both
legs. During the same period, the TUG Test, range of motion extension and left-knee flexion improved compared
with the control group, although these improvements had little clinical relevance.
Conclusions: We recorded statistically significant improvements compared with a control group with regard to
pain, quality of life and function for participants in the OAK program on the basis of WOMAC and SF-36 measures
taken 8 weeks and 6 months from baseline.
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Introduction
Osteoarthritis (OA) is the most common form of arthri-
tis and the third-leading cause of life-years lost to dis-
ability [1-3]. It affects 10% of the population and is
more common in women than in men. By age 65 years,
50% of the population have OA [1], and, as the popula-
tion ages in demographic terms, the prevalence of OA is
expected to rise. The knee is a commonly affected joint,
with a prevalence of OA of 40% in people age 65 years
or older [2].
Self-management (SM) is considered to be an effective
strategy in the treatment of chronic illnesses, including
OA [4]. Numerous SM programs have been developed
for different illnesses, such as diabetes, hypertension,
asthma and arthritis. Various models, both disease-spe-
cific and generic, have been employed, including indivi-
dual [5], group-based [6], post and internet programs
[7]. Most arthritis SM programs use lay leaders who
deliver a scripted program. Face-to-face interaction with
health care professionals is an important component of
some programs, especially when medication compliance
is considered relevant [4].
A number of studies have examined the effectiveness
of SM for people with arthritis [4,7,8]. One systematic
review of SM interventions for various chronic diseases
found a trend towards a small benefit from arthritis pro-
grams, the majority being Stanford University’s Arthritis
Self-Management Program (ASMP) [9] or derivatives of
the ASMP. The results were not significant, and publica-
tion bias was suspected [7]. A comparison of lay leaders
versus health care professional leaders has also been
published [7]; however, the study required all leaders,
both lay leaders and health care professionals, to deliver
the same scripted program, which limited the capacity
for the knowledge and skills of the health care profes-
sionals to be optimally utilised [10]. Given the design of
the study, it was not surprising that no differences were
demonstrated. Despite the popularity of layperson-led
SM programs for arthritis, and taking into account pos-
sible cost advantages, Taylor and Bury suggested that
such programs have little or no advantage in terms of
improved self-efficacy or the management of chronic ill-
ness [11]. Another study, by Hurley et al. [5], demon-
strated positive findings. They compared group and
individual rehabilitation programs run by physiothera-
pists in combination with SM and education (ESCAPE-
knee pain (Enabling Self-management and Coping with
Arthritic Knee Pain through Exercise)) with normal care
in 418 participants with knee OA. The authors found
that people in the ESCAPE-knee pain groups had better
functioning than those in the normal care group.
Although lay leaders have the potential to be role
models (as they often have musculoskeletal conditions
themselves), health care professionals, with their knowl-
edge and skills, can also have powerful influence as
models. A modelling approach has the potential to
transmit knowledge and skills to which people may
aspire, particularly if the information is perceived to be
important and relevant, resulting in behaviour changes
that are more likely to be maintained over the long
term [12]. This platform for behaviour change is con-
strained in layperson-led programs because of the lim-
ited knowledge of lay leaders.
Self-efficacy is an integral component of SM, and resi-
lience goes hand in hand with self-efficacy. Resilient
people tend to have well-developed self-efficacy and,
when confronted with an obstacle, will see it as a hurdle
to overcome rather than an insurmountable problem.
Furthermore, when repeated problems are encountered,
they are more likely to persist longer in attempting to
overcome them [13]. Those who attempt and succeed
will benefit in terms of improved self-efficacy.
Factors influencing self-efficacy, such as problem-sol-
ving, pain management, exercise, modelling, social per-
suasion, weekly goal-setting and cognitive therapy, are
interconnected. Pain management is important because
often people are hesitant to undertake new activities for
fear of pain, regardless of whether pain has previously
been experienced with that particular activity. Many
people with OA rely on medication for pain relief, but
are reluctant to take medication because of possible side
effects. Such people prefer to be aware of the pharmaco-
logic and treatment options available and then decide on
a course of management. If knowledge about the avail-
able options is lacking, however, the treatment choices
are more limited, and, importantly, this may have an
impact on adherence to treatment [14].
The lack of demonstrated benefits of SM in patients
with arthritis highlights the need to develop and test
alternative models of SM. In this report, we describe the
evaluation of an SM program for people with OA of the
knee, the Osteoarthritis of the Knee Self-Management
Program (OAK), which is designed to be delivered by
health care professionals.
People with OA may initially resist physical activity
due to discomfort, fear of pain, or previous advice to
avoid exercise [15,16]. Many believe that exercise will
result in bone and cartilage loss and are therefore resis-
tant to exercise in general [16], yet avoidance of activity
is known to contribute to disability long term [17]. The
OAK program includes general information about the
benefits of exercise and specific advice on joint protec-
tion during exercise for those with OA of the knee. The
program aims to maximize the benefits of physical activ-
ity and promote long-term adherence to an exercise
regimen by using structured exercise participation that
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is linked to weekly ‘SMART’ goals (Specific, Measurable,
Attainable, Realistic, Time-bound) [18]. The program
offers the added reassurance that health care profes-
sionals are on hand to give advice, and the group
dynamics offer incentives for participants to comply
with and maintain the exercise regimen. Participants’
success in meeting goals each week increases self-effi-
cacy [19], which is the strongest and most consistent
predictor of physical activity behaviour and its mainte-
nance over the long term [20]. Although exercise fea-
tures strongly in the OAK program, OAK is not an
exercise school. Exercise is only one component of the
program, and it is up to each individual to decide how
much emphasis is given to exercise from week to week
during the program.
Cognitive symptom management strategies are
encouraged to help eliminate ‘negative’ symptoms asso-
ciated with OA. Such negativity not only affects indivi-
dual symptom control but also contributes to and
exacerbates the symptoms of OA [21]. Guided imagery,
relaxation techniques, positive self-talk and problem-sol-
ving are taught to participants. These techniques enable
participants to understand how such influences contri-
bute to their symptoms and provide them with the skills
necessary to prevent the symptoms’ becoming an over-
whelming negative influence. Health care professionals
also use their knowledge to assist participants with pro-
blem-solving to overcome hurdles and promote resili-
ence [22].
Materials and methods
In this study, we sought to determine whether a disease-
specific SM program for people with osteoarthritis of
the knee (the OAK program), implemented by health
care professionals, would achieve and maintain clinically
meaningful improvements in health-related outcomes
compared with a control group. This study was
approved by the Human Research Ethics Committee at
Curtin University of Technology (HR141). Data access
and storage were in keeping with National Health and
Medical Research Council guidelines [23]. License agree-
ments were obtained for the Short Form 36 version 1
questionnaire (SF-36) and the Western Ontario and
McMaster Universities Arthritis Index questionnaire
(WOMAC).
The study design adhered to Consolidated Standards
of Reporting Trials Statement guidelines and intention
to treat principles. This trial was registered with the
Australia and New Zealand Clinical Trials Registry no:
12607000080426. The protocol has previously been
described in greater detail [24]. Amendments to the trial
protocol included analysis to determine participant’s
response to treatment (responders). This was necessary
to meet the requirements suggested in the Osteoarthritis
Research International Outcome Measures in Rheuma-
tology (OMERACT-OARSI) guidelines [25]. In addition,
the proportion of people attaining minimal clinically
important improvements (MCIIs) in WOMAC physical
function SF-36 domains, Visual Analogue Scale (VAS)
pain (at 8 weeks) and the Timed Up & Go Test (TUG)
was determined.
OAK program
The OAK program differs from other arthritis SM pro-
grams in a number of respects. It is a disease-specific
OA SM education program designed for delivery by
health care professionals. Its theoretical framework uses
Social Cognitive Theory [22] to enhance participants’
self-efficacy and promote long-term changes in beha-
viour. The results of an uncontrolled quality assurance
study of the OAK program were positive in terms of
improvement in pain, quality of life and physical func-
tion [26]. The program was designed specifically for
people with OA of the knee and for implementation in
a community-based setting, thus removing the burden
of health care at tertiary institutions. The education
component of this program is detailed, so delivery by
health care professionals is more appropriate than deliv-
ery by lay leaders. Principles and theories of SM are
used to promote behavioural change. In particular, exer-
cise and disease coping strategies are promoted within a
SM construct as a means of improving quality of life
and general health as well as reducing pain.
Health care professionals, including nurses, phy-
siotherapists and occupational therapists, who deliver
this program must have a minimum level of musculos-
keletal education to ensure that they have the necessary
knowledge and skills to present information about OA
of the knee and respond accurately to complex ques-
tions. The fidelity of the OAK program is maintained by
the use of a facilitators’ manual with modules for pro-
gram delivery each week that are designed specifically to
maintain the consistency and accuracy of the informa-
tion delivered.
The OAK program is conducted in a group setting
with six weekly sessions of 2.5 hours each, with a base-
line assessment 1 week before the start of the 6-week
SM program and a second assessment the week follow-
ing the completion of the program. This 8-week period
is referred to as the ‘clinic phase’. Attendance is volun-
tary; however, participants are encouraged to attend all
sessions. The program is designed so that participants
will progress over time by incorporating and consolidat-
ing information learned from week to week. In addition
to the weekly sessions, participants are given printed
information relevant to the course component discussed
each week. To facilitate optimum group dynamics, the
target group size is 12 participants.
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The program is implemented using a holistic approach
and addresses multiple aspects of care: osteoarthritis
(explanation and implications), SM skills (goal-setting,
problem-solving, modelling, positive thinking and
improving self-efficacy), medications (types, interactions
and current trends), correct use of analgesia (use, thera-
peutic dosing, types and side effects), pain management
strategies (cognitive and pharmacologic), fitness and
exercise (strength, flexibility, aerobic and balance), joint
protection, nutrition and weight control, fall prevention
(balance and proprioception), environmental risks, poly-
pharmacy and coping with negative emotions. The dif-
ferences between the OAK Program and the ASMP are
described in Table 1.
Study design
We conducted a two-group, randomised (1:1 ratio), con-
trolled, repeated-measures study to examine group differ-
ences regarding changes over time. Convenience sampling
was employed. The research sample was selected from
Table 1 Similarities and differences between the OAK program and ASMPa
Comparison parameters OAK ASMP
Similarities
Length of time 2.5 hours per week (6 weeks) 2.5 hours per week (6 weeks)
Group size 12 to 15 15 to 20















Occasional small groups or pairs of
participants
Small groups or pairs of participants in most sessions
Program fidelity Facilitator’s manual Facilitator’s manual
Training Leaders require training Leaders require training
Differences
Participants All with OA knee Various musculoskeletal conditions
Leaders Health professionals (n = 2) Trained leaders, one or both of whom are non-health-care professionals
with arthritis themselves [58]
Osteoarthritis Specific information on
• Anatomy of knee
• Pathophysiology
• Disease progression
• Specific treatment options
• Management of OA:
exercise, lifestyle, nutrition, weight loss
General overview of OA; no detailed explanations or pathophysiology
Nutrition
Exercise Actively encouraged
Detailed information every session
Greater emphasis on exercise
Instruction and demonstration with some
group participation
Exercise linked to goal-setting
General information on types of exercise





Medication Specific information on
• Types of medication
















aASMP: Arthritis Self-Management Program; NSAID: nonsteroidal anti-inflammatory drug; OA: osteoarthritis; OAK: Osteoarthritis of the Knee Self-Management
Program.
Coleman et al. Arthritis Research & Therapy 2012, 14:R21
http://arthritis-research.com/content/14/1/R21
Page 4 of 14
among people who were referred to the program. Suitable
candidates were invited to enrol in the OAK program.
Those who agreed to participate and provided their writ-
ten informed consent were randomised either to an OAK
group (immediate start) or to a control group (delayed
start). For ethical reasons, those participants who were
randomised to the control group were offered the oppor-
tunity to enrol in the OAK program at the conclusion of
the 6-month study. Independently of the study, all partici-
pants were allowed to continue standard medical manage-
ment for knee OA. Figure 1 shows the design of the study
and the time points at which the outcome measures were
recorded. All assessments were performed at Arthritis
Western Australia.
Participants
One hundred forty-six participants (37 male and 109
female) with established OA of the knee and mean (SD)
age of 65 (8) years were enrolled into the study from
primary care general practices. Inclusion and exclusion
criteria are listed in Table 2. All participants who were
recruited from the Perth metropolitan area and immedi-
ate surrounds provided their written informed consent
prior to enrolment.
Socioeconomic status was estimated according to resi-
dential postcodes using a method developed by the Aus-
tralian Bureau of Statistics: the Index of Relative Socio-
Economic Disadvantage [27]. The index provides a



















Figure 1: Study Design Flow Chart and evaluation tools used at each 
assessment. N=number of participants included in the data analyses. This 
includes values from returned posted questionnaires from non-attendees and last 


















Week 8 assessment 
N=69  
Week 8 assessment 
N=70 
6 month assessment 
N=68  











Knee ROM:  
Extension/flexion 
Timed up and go 
Figure 1 Study design flowchart and evaluation tools used at each assessment. The number of participants included the data analyses (N)
includes values from questionnaires returned by post by nonattendees and last value carried forward for other missing data. OAK: Osteoarthritis
of the Knee Self-Management Program; SF-36: Short Form 36 version 1 questionnaire; ROM: range of motion; VAS: Visual Analogue Scale;
WOMAC: Western Ontario and McMaster Universities Arthritis Index.
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disadvantage and a high index value representing advan-
tage (Table 3).
During the recruitment phase, the OAK program was
actively promoted to general practitioners, rheumatolo-
gists and health care professionals through professional
societies and to the general public through advertising
and media coverage. Invitations were also extended to
those people with OA of the knee who made general
inquiries to Arthritis Western Australia. The OAK pro-
gram and all assessments were conducted at Arthritis
Western Australia, a community setting that is close to
public transport and has available infrastructure to run
the program and coordinate the study. This project was
funded with in-kind support from Arthritis Western
Australia. The research undertaken was independent
from the funding body.
Table 2 Eligibility criteriaa
Inclusion criteria Exclusion criteria
English-speaking Coexisting inflammatory arthritis
Age 18 years or older Serious comorbidity
Diagnosis of OA (X-ray or clinical diagnosis) Knee replacement scheduled in < 6 months
Referral from general practitioner or specialist Cannot meet program time points
Able to meet program requirements
aOA: osteoarthritis.
Table 3 Characteristics of participants enrolled in an OAK programa
Characteristics Control OAK P value
Mean age (SD), years 65 (8.7) 65 (7.9)
Gender (M:F) 23:52 14:57
Socioeconomic index by post code [27] in quintiles, n (%)
Top 25% 43 (57) 46 (65)
50% to 75% 10 (13) 9 (13)
25% to 50% 6 (8) 8 (11)
10% to 25% 11 (15) 6 (8)
Bottom 10% 5 (7) 2 (3)
Coexisting disease, n (%)a
Total number 156 156
Cardiovascular 48 (64) 56 (79)
Gastrointestinal 17 (22) 21 (29)
Musculoskeletal (other than knee OA) 32 (43) 12 (17)
Mental health 6 (8) 7 (10)
Endocrine 18 (24) 13 (18)
Osteoporosis 8 (11) 8 (11)
Other 27 (36) 39 (55)
None 9 people (12%) 6 people (8.5%)
Multiple coexisting diseases 49 people (65%) 43 people (60%)
Mean (SD) incidence per person 2.39 (1.4) 2.43 (1.65)
SF-36b
Physical function 43.98 (21.2) 50.41 (22.2) 0.078
Role physical 28.38 (36.6) 40.00 (39.7) 0.070
Body pain 42.00 (19.1) 49.73 (19.0) 0.016
General health 64.81 (17.2) 65.05 (18.4) 0.936
Vitality 52.70 (21.0) 55.86 (16.4) 0.321
Social function 69.43 (26.1) 75.54 (22.1) 0.133
Role emotional 57.66 (43.1) 66.19 (42.6) 0.235
Mental health 74.92 (15.1) 75.94 (14.8) 0.683
WOMAC pain 8.00 (3.6) 6.53 (3.7) 0.020
aOA: osteoarthritis; OAK: Osteoarthritis of the Knee Self-Management Program; SF-36: Short Form 36 version 1 questionnaire; WOMAC: Western Ontario and
McMaster Universities Arthritis Index. bPercentage adds to > 100% because some participants had more than one coexisting disease. cUnadjusted baseline values,
mean (SD) control and OAK groups.
Coleman et al. Arthritis Research & Therapy 2012, 14:R21
http://arthritis-research.com/content/14/1/R21
Page 6 of 14
Randomisation and blinding
Participants were allocated to study groups using simple
randomisation performed in batches of approximately
24 depending on recruitment success. Once a group of
24 volunteers were recruited, they were randomised to
either the OAK or the control group. Twenty-four pre-
made cards (twelve interventions and twelve controls) in
sealed opaque envelopes were placed in a box. An envel-
ope was drawn from the box by an independent person
to determine group allocation. Blinding of participants
was not possible, owing to the nature of the interven-
tion; however, the physiotherapists performing the
assessments did not participate in the facilitation of the
OAK program and thus were blind to group allocation.
To maintain blinding, the physiotherapists were asked
not to discuss group allocation with the participants
during assessments.
Outcome measures
The outcome measures included both primary and sec-
ondary measures. The primary measures were health
status, measured using the self-administered WOMAC
Osteoarthritis Index for OA of the knee (WOMAC
LK3.0) [28,29]; and quality of life, measured using the
SF-36 questionnaire [30,31].
The secondary measures were VAS pain [32,33]
assessed at weekly intervals in the OAK group during
the delivery of the knee OA program from baseline to
the 8-week assessment, whereas the control group was
assessed for VAS pain scores at baseline and at week 8
(see Figure 1). Functional mobility was assessed using a
modified TUG test [34-36]. For this study, ascending
and descending a 15-cm step was added to the outward
walk. Two measurements were performed, and the aver-
age of these measurements was used for analysis. Range
of motion of the knee joints was measured using a long-
armed goniometer [37,38]. Isometric strength of the
hamstrings and quadriceps muscles measured at 90°
knee flexion using a Mecmesin force gauge dynam-
ometer (Slinfold, UK) [39]. Parameters for each knee
were measured three times. The first (practice) measure-
ment was excluded. The two subsequent measures were
averaged for analysis.
The number of responders and MCIIs achieved by
participants were calculated in addition to primary and
secondary outcome measures to meet the OMERACT-
OARSI guidelines [25].
Statistical power calculation
An a priori power calculation based on the quality-of-
life outcome as measured by the SF-36 [30] was under-
taken. The SF-36 was chosen because it is the least sen-
sitive instrument and requires a greater sample size to
detect changes in treatment differences with respect to
pain and physical functioning in people with OA [40].
Sample size was calculated according to guidelines in
the SF-36 Users Manual to determine differences in
changes over time between the intervention and control
groups using a repeated-measures design, allowing an
intertemporal correlation of 0.60 between scores [30].
Previously, the OAK program quality assurance study
SF-36 data showed an average difference of 10 points
across the eight domains measured [26]. Assuming that
this level of improvement was likely to be achieved in
the OAK group and that no change was expected in the
control group, and allowing for a 10% dropout rate, the
number of participants was calculated to be 60 [30]. In
the quality assurance study, the dropout rate was 5%
over 3 years, so allowing for a 10% dropout rate was a
conservative estimate. Differences in changes in func-
tional ability measured using the WOMAC question-
naire, which were similar in magnitude to those
previously documented [41], would also be detectable in
a sample of this size.
Data analysis
Data were analysed in a blinded manner using SPSS ver-
sion 17 for Macintosh software (SPSS, Inc, Chicago, IL,
USA). Treatment groups were examined for comparabil-
ity at baseline. Despite randomisation, there were
between group differences in severity at baseline. There-
fore, baseline values (recorded in Table 3) were used as
covariates in the analyses [42]. This had the effect of the
preintervention mean (SEM) values’ being the same at
baseline in both groups. The main comparisons between
groups were performed using an intention-to-treat ana-
lysis. All participants were encouraged to attend follow-
up measurement sessions, regardless of their level of
participation in the program. Where data were missing,
the previous value was carried forward. To test the
effects of treatment, between-group differences in
changes over time (baseline, 8 weeks and 6 months)
were examined using repeated-measures analysis of cov-
ariance. A separate analysis was conducted for each out-
come variable.
For secondary analyses, a favourable response to treat-
ment (responder) was recorded as defined by the
OMERACT-OARSI criteria [25]. We used scenario D:
an improvement of ≥ 50% and an absolute change of ≥
20 points on a 100-point scale in pain or function or an
improvement in at least two of the following: an
improvement of ≥ 20% and an absolute change of ≥ 10
points in two of the three parameters pain, function and
global health. Because patients’ global health was not
recorded in this study, however, only the pain and func-
tion sections of the second alternative were available.
Furthermore, the proportion of participants achieving
MCIIs independently in terms of health status, quality
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of life, pain and the TUG test were computed for each
group at each observation time point. The criteria for
the MCIIs were as follows [43]:
1. Health status using WOMAC Physical Function (0
to 100)
a. Absolute change -9.1 points
b. Percentage change: -26.0%
2. VAS Pain score
a. Absolute change -1.99 points
b. Percentage change -40.8%
3. Quality of life using the SF-36 questionnaire (Body
Pain and Physical Function domains)
a. Absolute change +5 points
4. TUG test
a. Percentage change -9%
The proportion of participants achieving MCIIs and
the responder criteria were computed for each group at
each observation time. A Pearson’s c2 test not sure what
the underscore is here was used to examine the effect of
the treatment in terms of the proportion of MCIIs and
responders. Statistical significance was inferred at a two-
tailed P value < 0.05. The results were not adjusted for
multiple comparisons, because all outcomes of interest
were nominated a priori and such adjustment would
likely have rendered all findings of interest, despite their
clinical importance, nonsignificant [44].
Results
Table 3 shows the number, characteristics and distribu-
tion of all subjects. The male-to-female ratio was not
significantly different between groups (Pearson’s c2 =
2.311(1,146), P = 0.182). Sixty-eight participants from
each group were assessed at 6-month follow-up exami-
nations. All participants in the intervention group (OAK
group) included in the analyses attended at least four of
the six SM sessions. The mean (median) attendance in
the OAK group was 5.77 (6) sessions. The reasons cited
for withdrawal were overseas relocation; work, family
and time commitments; and not having been rando-
mised to the OAK group. Participants from the highest
socioeconomic group were overrepresented, and
approximately 90% had coexisting disease (Table 3).
Mean differences
Primary measures
WOMAC Pain, Physical Function and Total scores
improved more significantly in the OAK group than in
the control group (Table 4). The advantage in between-
group differences in changes was evident in the Physical
Function and Total scores at posttreatment and 6-month
follow-up; by 6 months posttreatment, however, the
improvements in Pain scores were comparable between
groups. There were improvements from baseline to 8
weeks in the SF-36 scales Physical Function, Role
Physical, Body Pain, Vitality and Social Function in the
OAK group compared with the control group. These dif-
ferences were maintained at 6 months (Table 4).
Secondary measures
A trend in pain improvement that corresponded with an
increase in exercise was noted in the quality assurance
study. Therefore, VAS scores were assessed during the
intervention phase of the study to track pain during the
OAK course.
In the OAK group, VAS pain decreased 30% during
the 8-week intervention phase (mean (SE) 5.21 (0.30) to
3.65 (0.29), P ≤ 0.001), and the control group had a 17%
increase in pain (5.27 (0.30) to 6.19 (0.32), P ≤ 0.001)
during the same period. The difference in the mean
change between groups, from baseline to week 8, was
2.54 cm (95% CI = 1.66 to 3.41). The TUG test results
showed a significant improvement in the OAK group
compared with the control group postintervention and
at 6 months; however, the improvement was small
(Table 5) [45]. A MCII for TUG was observed in three
times as many OAK group participants as control group
participants at 8 weeks (OAK = 46 and control group =
15); however, this ratio was appreciably lower at 6
months (OAK = 38 and control = 26).
Hamstring strength improved in both right and left
legs in the OAK group compared with the control
group. In the right hamstrings, there was a 34%
improvement postintervention and a 29% improvement
at 6 months. In the control group, improvements of
10% postintervention and 14% at 6 months were
achieved. Similar improvements were observed in the
left hamstrings (Table 5). Despite the significance of
these results, they have little clinical meaning because of
the limited magnitude of the improvement. There was
no significant difference between groups in quadriceps
strength in either the left or right legs.
Small increases in range of motion were observed.
Extension in both knees and flexion of the left knee in
the OAK group improved significantly compared with
the control group; however, these improvements also
were of questionable clinical significance because of the
magnitude of the improvement.
Responders
Following the intervention, the proportion of responders
in the OAK group at 8 weeks was more than three
times that in the control group (Table 6). At this post-
treatment assessment, 26 people from the OAK group
and 8 from the control group were classified as respon-
ders according to the prespecified criteria for response
to treatment [46]. There were 22 responders in the
OAK group compared to 14 in the control group at 6
months; however, the difference between groups was
not statistically significant at that time point.
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Minimal clinically important improvements
The OAK group had a greater proportion of MCIIs on
all outcome measures at all time points compared with
the control group. The differences were significant for
all variables apart from SF-36 Body Pain scale at 8
weeks and the SF-36 Physical Function and Body Pain
scales at 6 months (Table 6). The proportion of MCIIs
between the OAK and control groups was greatest
immediately after intervention. In the OAK group,
approximately three times as many participants were
achieved a MCII compared with the control group at 8
weeks and almost twice the number at 6 months.
Discussion
In this randomised controlled trial, we have demon-
strated that participants in a SM program designed spe-
cifically for people with OA of the knee and delivered
by health care professionals experienced improvements
in a number of health domains that people with OAK
have identified as important problems associated with
their condition [47].
SM aims to motivate people to undertake the changes in
behaviour necessary to improve their condition. The prio-
rities of people with OA knee have been identified as pro-
blems with pain and activities of daily living, and their
preference is to actively manage their condition [14,47].
The OAK program was designed as a community-based
SM education program that aims to improve pain, func-
tion and quality of life and to empower people to address
these preferences with the support of health care profes-
sionals who have expertise in this area. The OAK program
incorporates education with an emphasis on OA-related
information and the benefits of exercise within SM con-
structs to promote improved self-efficacy and changes in
behaviour. Utilising the knowledge and skills of health
care professionals is a chief component of the OAK pro-
gram because knowledge is an important part of self-effi-
cacy in that no amount of confidence will produce success
unless the required knowledge and skills are present [48].
The mechanisms involved in successful SM are not
well-understood. The highly structured nature of the
intervention may be important, and other nonspecific
Table 4 Results for primary outcomes based on WOMAC and SF-36: preintervention (baseline), postintervention (8
weeks) and 6 monthsa
Variables OAK and control
preinterventionb




































































































































































aOAK: Osteoarthritis of the Knee Self-Management Program. SF-36: Short Form 36 version 1 questionnaire; WOMAC: Western Ontario and McMaster Universities
Arthritis Index. bPreintervention values were the same in both groups when the baseline value was used as a covariate. Values were calculated using repeated-
measures analysis of covariance with the baseline value of the dependent variable as the covariate. Data are estimated marginal means (SEM) with the mean
(95% CI) differences in changes between the groups at each time point. cP < 0.05 for baseline to 6 months.
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aOAK: Osteoarthritis of the Knee Self-Management Program; TUG: Timed Up & Go Test. bPreintervention values were the same in both groups when the baseline
value was used as a covariate. cP < 0.05. Preintervention (baseline), postintervention (8 weeks) and 6-month values were calculated using repeated-measures
analysis of covariance with the baseline value of the dependent variable as the covariate. Data are estimated marginal means (SEM) with the mean (95% CI)
difference in changes between the groups at each time point.
Table 6 MCII and participant responders based on changes between baseline and 8 weeks and between baseline and
6 months
Number with MCII (%)
Variables Pearson’s c2 P values OAK Control
Preintervention to 8 weeks
WOMAC Physical Function, absolute 10.84(1, 141) P = 0.001 25 (37%) 9 (13%)
WOMAC Physical Function (%) 19.34(1, 141) P ≤ 0.001 29 (43%) 7 (10%)
SF-36 Physical Function 8.34(1, 140) P = 0.006 40 (60%) 23 (34%)
SF-36 Pain 1.38(1, 139) P = 0.265 23 (34%) 17 (25%)
VAS Pain, absolute 15.95(1, 139) P ≤ 0.001 27 (40%) 7 (10%)
VAS Pain (%) 17.37(1, 139) P ≤ 0.001 25 (37%) 5 (7%)
TUG 28.87(1, 139) P ≤ 0.001 46 (69%) 15 (22%)
Responders 13.59(1, 141) P ≤ 0.001 26 (39%)
b 8 (12%)b
Preintervention to 6 months
WOMAC Physical Function, absolute 3.87(1, 135) P = 0.057 24 (14%) 14 (20%)
WOMAC Physical Function (%) 4.37(1, 135) P = 0.043 27 (40%) 15 (22%)
SF-36 Physical Function 2.93(1, 136) P = 0.122 40 (60%) 29 (43%)
SF-36 Pain 0.95(1, 135) P = 0.384 31 (46%) 25 (37%)
TUG 5.10(1, 132) P = 0.036 38 (57%) 26 (38%)
Responders 2.58(1, 135) P = 0.123 22 (33%)
b 14 (20%)b
aMCII: minimal clinically important improvement; OARSI: Osteoarthritis Research International; OMERACT: Outcome Measures in Rheumatology; SF-36: Short Form
36 version 1 questionnaire; TUG: Timed Up & Go Test; VAS: Visual Analogue Scale; WOMAC: Western Ontario and McMaster Universities Arthritis Index. bData are
number of responders based on the OMERACT-OARSI criteria [46].
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mechanisms such as group dynamics may be contribu-
tory. Nevertheless, there appears to be consensus that
the efficacy is likely to be due at least in part to
increased adherence to medications [4]. This is a posi-
tive effect, especially in people with chronic diseases, for
whom compliance (adherence and persistence) with all
measures, including pharmacologic ones, are important
in optimal management. It should be noted that in the
OAK program, educational material concerning pharma-
cologic therapy and pain relief are included in the
syllabus.
The WOMAC and SF-36 questionnaires are both
tools that can demonstrate improvements in pain and in
overall health status [49]; in people with OA, however,
the WOMAC questionnaire is more sensitive than the
SF-36 to changes in pain and physical function [40].
Improvements in pain scores demonstrated on the VAS
(weeks 1 to 8) were also reflected on the WOMAC and
SF-36 questionnaires in the OAK group compared with
the control group, and, moreover, they were maintained
to 6 months.
Similarly, in the OAK group, a significantly greater
proportion of responders were observed at 8 weeks
compared with the control group, though by 6 months
this proportion did not differ significantly between
groups. Reviews of SM show that there is a decline in
the extent of improvements by 6 months. This decline
is commonly observed in such studies and highlights the
limited duration of the benefit that accrues due to SM
in the management of OA of the knee, which, of course,
requires long-term care [8,11,50]. These and other
observations attest to the need for more research in this
area, especially studies which investigate the differences
in cost between SM programs that utilize health care
professionals and layperson-led SM programs.
Determining the value that patients place on improve-
ments in pain can be difficult. In studies in which
patients were treated with nonsteroidal anti-inflamma-
tory drugs (rofecoxib or ibuprofen), patients have per-
ceived improvements of 9% to 10% in WOMAC scores
as beneficial for OA of the knee [51]. The OAK group
demonstrated better improvements in WOMAC pain of
23% between pre- and postintervention and of 13.7%
from preintervention to 6 months. By contrast, at the
same time points, the control group had improvements
of 2.3% and 7% in WOMAC pain.
One limitation of the OAK/control study is that it
compared a treatment program with a no-treatment
control group. Therefore, the only blinding that could
be maintained was assessor blinding, an important con-
sequence of which is the risk of reporting, attrition and
other types of bias. In addition, self-reported pain may
be affected by bias, as patients are keen to ‘do well’ and
to please health care providers by reporting an
improvement when there may not have been one. More-
over, the perception of the efficacy of the treatment by
the health care providers may influence how the patients
perceive their pain and thus may result in an improved
pain rating [52], suggesting that the bias related to no-
treatment control groups is generally underestimated
[53].
As with pain, there were significant improvements in
quality of life and function in the OAK group compared
to the control group, with improvements seen in
WOMAC and SF-36 scores maintained to 6 months.
Physical improvements were also maintained at 6
months compared with the control group. Self-reported
functional outcome measures tend to be influenced by
pain, so it is important to have functional as well as
self-reported outcome measures because the combina-
tion allows a more realistic appraisal of functional ability
than self-reported outcome alone [54].
The control group also demonstrated improvements
in many outcomes. It is difficult to explain these
improvements other than patient-provider interactions
at assessments. Patients in untreated control groups
may interact with health care providers. Hróbjartsson
and Gøtzsche [53] suggested that the possibility of
patient-provider interactions could have clinically useful
effects. For example, there may have been a ‘Hawthorne’
effect, which is described as the awareness of being
involved in a trial with resulting altered (that is,
improved) behaviour or performance [55]. There was
also an unexpected improvement in the number of
responders in the control group from 8 weeks to 6
months. Using last value carried forward (LVCF) to
replace missing data assumes that the participant’s
responses would have been constant from the beginning
to the end of the study, and this assumption can result
in the false conclusion that a difference exists when in
fact there is none [56]. Using the LVCF creates the
impression that the participant is in a state of equili-
brium, neither better nor worse, an outcome that could
be perceived as beneficial in terms of disease progres-
sion in OA because OA is a condition that generally
deteriorates over time. This has the potential to bias the
estimates of treatment effect [57].
Strategies to retain the study population included tele-
phone and written notification of follow-up assessments,
offers to reschedule missed assessment appointments
and telephone contact to encourage rescheduling of
assessments. Attendance at assessments at week 8 was
96% in the OAK group and 85% in the control group.
The difference may be explained by some participants in
the control group assuming that because the control
period was 6 months, their participation was not
required until that point. At 6 months, participation was
relatively unchanged, with the OAK group’s attendance
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being 93% and the control group’s being 85%. All nonat-
tending participants received posted self-report ques-
tionnaires with postage-paid, self-addressed envelopes
enclosed. Not all participants returned the question-
naires. Although the posted questionnaires captured
self-reported outcomes, they did not capture physical
assessments, and other missing values were recorded
with the LVCF, which is consistent with an intention-
to-treat analysis.
Within-group improvements were evident on the
WOMAC (Stiffness and Total scores) and the SF-36
(Physical Function, Role Physical, General Health and
Vitality). The significant improvements seen in ham-
string strength, but not quadriceps strength, are difficult
to explain. The OAK program is not an exercise pro-
gram, and, although participants are encouraged to exer-
cise, the exercises are delivered within a SM format that
requires individuals to adopt an exercise regimen that
best meets their needs.
The highest socioeconomic group was overrepresented
in this study. It is possible that the study results might
overstate their likely impact on the wider community,
because there is the potential for people with higher
education levels to have better outcomes. Arthritis Wes-
tern Australia is located in a middle socioeconomic
area. Previous attempts to recruit from lower socioeco-
nomic areas had limited success. Strategies for outer
metropolitan and rural clinics were discussed and may
be pertinent for future studies. Another possible limita-
tion of this study is the self-initiated enrolment, which
might produce potential bias because those people who
volunteer may already be positively predisposed to SM
[11,50].
These results reflect the improvements seen in a pre-
viously reported quality assurance study in which the
OAK program was tested [26]. The use of a more rigor-
ous study design further strengthens the earlier findings.
The combined information should prove useful for plan-
ning future models of SM in arthritis care. Although the
use of health care professionals as facilitators will add to
the cost of such care, there is only weak evidence to
support SM programs that use lay leaders. Cost analysis
was not within the scope of this study. Future research
comparing the OAK program with a lay leader SM pro-
gram should be undertaken to determine the most effec-
tive model.
Conclusions
In participants with OA of the knee, statistically signifi-
cant improvements in pain, quality of life and function
were observed in the group randomised to an OAK
intervention program delivered by health care profes-
sionals compared with those randomised to a control
group. The number of participants achieving MCIIs and
responder criteria at 8 weeks and 6 months in the OAK
group compared with the control group adds strength
to these findings.
Future research is recommended to compare and esti-
mate the cost of the OAK program in comparison to
other SM models, in particular the ASMP. A compari-
son with ASMP would help to determine whether a pol-
icy shift between lay leaders and health care
professionals is justified. Comparison of the OAK pro-
gram and an exercise-alone program may provide useful
information regarding the improvements noted in the
OAK group. Such studies should incorporate longer fol-
low-up assessments.
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